GSTM1 and cryohydrocytosis: Levels of Hb (13.2 ± 2.1 versus 14.4 ± 2.0 g/dL at baseline) in peripheral blood during the NCT and SOC in CHC patients with genotype 1b and high viral load were significantly higher among patients receiving the NCT compared with patients receiving the SOC at week 12 (12.6 ± 1.7 versus 10.8 ± 1.9, P = 0.0767) and at week 24 (12.3 ± 1.2 versus 10.8 ± 1.8, P = 0.0641) (Figure 14).